Gensler's resignation as SEC Chair marks a shift in crypto regulation, with Trump's successor potentially more favorable to Wall Street and the industry.
Novartis raises mid-term sales guidance, citing strong drug performance and promising pipeline, but analysts express concerns about sustaining growth beyond 2029.
Musk and Bezos, two tech titans, reignite their long-standing rivalry over election claims and political ties.
Gensler's resignation as SEC Chair marks a shift in crypto regulation, with Trump's successor potentially more favorable to Wall Street and the industry.
Novartis raises mid-term sales guidance, citing strong drug performance and promising pipeline, but analysts express concerns about sustaining growth beyond 2029.
Musk and Bezos, two tech titans, reignite their long-standing rivalry over election claims and political ties.